Efficacy and safety of low‐dose antihypertensive combination of amlodipine, telmisartan, and chlorthalidone: A randomized, double‐blind, parallel, phase II trial

Efficacy and safety of low‐dose antihypertensive combination of amlodipine, telmisartan, and chlorthalidone: A randomized, double‐blind, parallel, phase II trial

Abstract The aim of this clinical trial was to assess the efficacy and safety of low‐dose triple combinations of amlodipine, telmisartan, and chlorthalidone in patients with essential hypertension. After a 2‐week placebo run‐in period, 176 patients were randomized to seven treatment groups (placebo,...

Full description

Bibliographic Details
Main Authors: Ki‐Chul Sung, Jung Hoon Sung, Eun Joo Cho, Jeong Cheon Ahn, Seung Hwan Han, Weon Kim, Kye Hun Kim, Il Suk Sohn, Jinho Shin, Seok Yeon Kim, Kwang‐il Kim, Seok Min Kang, Sung‐Ji Park, Yong‐Jin Kim, Joon‐Han Shin, Seong‐Mi Park, Chang‐Gyu Park
Format: Article
Language:English
Published: Wiley 2022-10-01
Series:The Journal of Clinical Hypertension
Subjects:
amlodipine
chlorthalidone
hypertension
low‐dose combination
telmisartan
Online Access:https://doi.org/10.1111/jch.14570

Internet

https://doi.org/10.1111/jch.14570

Similar Items